Cargando…
Serum PAI-1/BDNF Ratio Is Increased in Alzheimer’s Disease and Correlates with Disease Severity
[Image: see text] We previously demonstrated that serum levels of plasminogen activator inhibitor-1 (PAI-1), which inhibits both the tissue plasminogen activator (tPA) and plasmin activity, are increased in patients with Alzheimer’s disease. tPA/plasmin not only prevents the accumulation of β-amyloi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552510/ https://www.ncbi.nlm.nih.gov/pubmed/37810633 http://dx.doi.org/10.1021/acsomega.3c04076 |